https://www.biospace.com/deciphera-pharmaceuticals-announces-first-quarter-2023-financial-results
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results - BioSpace
May 3, 2023 - Deciphera Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2023 and provided a corporate update.
deciphera pharmaceuticalsfirst quarterfinancial resultsannounces2023
https://www.fool.com/earnings/call-transcripts/2021/11/03/deciphera-pharmaceuticals-inc-dcph-q3-2021-earning/
Deciphera Pharmaceuticals, inc (DCPH) Q3 2021 Earnings Call Transcript | The Motley Fool
Nov 3, 2021 - DCPH earnings call for the period ending September 30, 2021.
earnings call transcriptdeciphera pharmaceuticals
https://www.oanda.com/eu-en/trading/shares/us/deciphera-pharmaceuticals
Deciphera Pharmaceuticals Inc (DCPH) Trading | Shares / Shares CFDs | OANDA
Trade Deciphera Pharmaceuticals Inc (DCPH) shares CFDs with OANDA. View live charts and current market interest for this stock.
deciphera pharmaceuticalsshares cfdsincdcphtrading
https://www.benzinga.com/general/biotech/23/08/33716646/deciphera-pharmaceuticals-sees-renewed-competitive-edge-after-theseus-pan-kit-discontinuation-ana
Deciphera Pharmaceuticals Sees Renewed Competitive Edge After Theseus Pan-KIT Discontinuation:...
Aug 10, 2023 - Stifel upgraded Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) to Buy from Hold, with a price target of $20 from $14, after reevaluating the competitive...
deciphera pharmaceuticalscompetitive edgeseesrenewed
https://www.benzinga.com/news/earnings/23/02/30738253/earnings-outlook-for-deciphera-pharmaceuticals
Earnings Outlook For Deciphera Pharmaceuticals - Benzinga
earnings outlookdeciphera pharmaceuticalsbenzinga
https://www.biospace.com/medison-pharma-enters-exclusive-distribution-agreement-with-deciphera-pharmaceuticals-to-commercialize-qinlock-ripretinib-in-a-multi-regional-agreement
Medison Pharma Enters Exclusive Distribution Agreement with Deciphera Pharmaceuticals to...
Nov 6, 2020 - Medison Pharma, a leading international commercial partner for highly innovative therapies, today announced an exclusive distribution agreement with Deciphera...
exclusive distributiondeciphera pharmaceuticalsmedisonentersagreement
https://robinhood.com/us/en/stocks/DCPH/
Deciphera Pharmaceuticals: DCPH Stock Price Quote & News | Robinhood
You can watch DCPH and buy and sell other stocks, ETFs, and their options commission-free on Robinhood. Change the date range, see whether others are buying or...
stock price quotedeciphera pharmaceuticalsdcphnewsrobinhood
https://www.biospace.com/deciphera-pharmaceuticals-presents-preliminary-data-from-phase-1b-2-study-of-rebastinib-in-combination-with-paclitaxel-in-patients-with-advanced-endometrial-cancer-at-the-asco-2020-virtual-scientific-program
Deciphera Pharmaceuticals Presents Preliminary Data from Phase 1b/2 Study of Rebastinib in...
May 29, 2020 - Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced the presentation of data from the endometrial cancer cohort of Part 2 of its ongoing Phase 1b/2...
https://www.biospace.com/deciphera-pharmaceuticals-presents-data-from-rebastinib-and-dcc-3116-programs-at-the-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics
Deciphera Pharmaceuticals Presents Data from Rebastinib and DCC-3116 Programs at the AACR-NCI-EORTC...
Oct 28, 2019 - Deciphera Pharmaceuticals, Inc. (Nasdaq:DCPH), a clinical-stage biopharmaceutical company addressing key mechanisms of tumor drug resistance, today presented...
https://www.biospace.com/deciphera-pharmaceuticals-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-september-15-2023
Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -...
Sep 18, 2023 - Deciphera Pharmaceuticals, Inc. announced that in connection with the hiring of Dashyant Dhanak, Ph.D., Executive Vice President and Chief Scientific Officer,...